Made available in DSpace on 2014-10-09T12:42:42Z (GMT). No. of bitstreams: 0 / Made available in DSpace on 2014-10-09T14:02:12Z (GMT). No. of bitstreams: 1 05232.pdf: 6473842 bytes, checksum: 88d593005dc2c79ae422916e7fcaf0d9 (MD5) / Tese (Doutoramento) / IPEN/T / Instituto de Pesquisas Energeticas e Nucleares - IPEN/CNEN-SP

Made available in DSpace on 2014-10-09T12:41:40Z (GMT). No. of bitstreams: 0 / Made available in DSpace on 2014-10-09T14:07:26Z (GMT). No. of bitstreams: 0 / Antes de se iniciar os estudos clínicos de uma nova droga, é necessário realizar uma bateria de testes de segurança, para avaliar o risco humano. Os radiofármacos como qualquer outra nova droga, devem ser testados levando em conta sua especificidade, duração de tratamento e principalmente a toxicidade de ambas as partes, a molécula não marcada e a sua radioatividade em si, além das impurezas provindas da radiólise. Órgãos regulatórios como o Food and Drug Administration-EUA (FDA) e a Agência de Medicina Européia (EMEA), estabelecem guias para a regulamentação de produção e pesquisas de radiofármacos, No Brasil a produção de radiofármacos não era regulamentada até o final de 2009, quando foram estabelecidas pela Agência Nacional de Vigilância Sanitária (ANVISA) as resoluções nº 63, que visa as Boas Práticas de Fabricação de Radiofármacos e a nº 64 que visa o registro do radiofámaco. Para a obtenção do registro de radiofármacos são necessárias a comprovação da qualidade, segurança, eficácia e especificidade do medicamento. Para a segurança dos radiofármacos devem ser apresentados estudos de toxicidade aguda, subaguda e crônica como também a toxicidade reprodutiva, mutagênica e carcinogênica. Hoje o IPEN-CNEN/SP produz um dos radiofámacos mais importantes da medicina nuclear, o 18F-FDG, que é utilizado em muitas aplicações clínicas, em particular no diagnóstico e estadiamento de tumores. O objetivo deste trabalho foi avaliar a toxicidade sistêmica (aguda/subaguda) do radiofármaco 18F- FDG em um sistema teste in vivo, conforme preconiza a RDC nº 64, que servirá de modelo para os protocolos de toxicidade dos radiofármacos produzidos no IPEN. Os ensaios realizados foram: os testes de toxicidade aguda e de toxicidade subaguda, estudos de biodistribuição do 18F-FDG, ensaio cometa e toxicidade reprodutiva. Na toxicidade aguda, ratos sadios foram injetados com 18F- FDG e observados durante 14 dias enquanto na toxicidade subaguda os animais foram observados durante 28 dias. Os resultados não mostraram nenhuma evidência de toxicidade na exposição ao 18F-FDG na toxicidade aguda e na subaguda. A biodistribuição demonstrou resultados semelhantes aos da literatura, onde a bexiga é o órgão que mais recebe radiação. O ensaio cometa mostrou que a radiação do radiofármaco não foi significativa para gerar danos no DNA. Na toxicidade reprodutiva, casais de ratos expostos ao 18F-FDG geraram filhotes completamente normais e saudáveis. Por fim, o 18F-FDG não evidenciou nenhuma toxicidade. / Dissertação (Mestrado) / IPEN/D / Instituto de Pesquisas Energeticas e Nucleares - IPEN-CNEN/SP

[pt] Neste trabalho são apresentados os efeitos nas propriedades mecânicas, estruturais e tribológicas da incorporação de flúor em filmes de carbono amorfo hidrogenados depositados por Deposição na Fase Vapor Assistido por Plasma . A estabilidade térmica de filmes de carbono amorfo fluorados também foi estudada. Os filmes foram depositados a partir de uma mistura dos gases C2H2 e CF4 com uma tensão de autopolarização de - 350V. A mistura de gases da deposição foi variada de uma concentração de 0% até 90% de CF4. A estabilidade térmica foi verificada em filmes depositados com 50% de C2H2 e 50% de CF4 na atmosfera precursora. Os filmes foram submetidos a temperaturas variando de 200oC a 600oC por 30 minutos. As propriedades mecânicas, estruturais e tribológicas dos filmes foram estudados com o uso de técnicas nucleares (retroespalhamento de Rutherford e Detecção por recuo elástico), espectroscopia Raman, espectroscopia de fotoelétrons induzida por raios-X, perfilometria (tensão interna), nanoindentação (dureza), de microscopia de força atômica e de ângulo de contato. Os resultados obtidos mostraram que a incorporação de flúor produzem filmes com as propriedades indo em direção às propriedades do Teflon. Os filmes ricos em flúor são menos densos, mais macios, mais hidrofóbicos e tem um menor coeficiente de atrito do que filmes de carbono amorfo hidrogenados. O tratamento térmico realizado mostrou que os filmes são estáveis a temperaturas de até 300oC. A partir desta temperatura os filmes sofreram perda de flúor e mudanças nas suas propriedades indicando a formação de uma estrutura mais grafítica. / [en] This work presents the effects on the mechanical, structural and tribological properties of the incorporation of fluorine in amorphous carbon films deposited by PECVD (Plasma Enhanced Chemical Vapor Deposition). The thermal stability of fluorinated amorphous carbon films was also studied. The films were deposited using mixtures of C2H2 and CF4 gases with a self-bias voltage of - 350V. The concentration of CF4 in the gases mixture was varied from 0% to 90%. The thermal stability was investigated in films deposited with 50% C2H2 and 50% CF4 as precursor atmosphere. These films were annealed in the temperatures range of 200oC to 600oC during 30 minutes for each sample. The mechanical, structural and tribological properties were studied using nuclear techniques (Rutherford Backscattering and Elastic Recoil Detection Analysis), Raman and X-ray photoelectron spectroscopy, profilometry (for internal stress) and nanoidentation (for hardness), atomic force microscopy and contact angle measurements. The results showed that fluorine incorporation produces films with properties resembling the Teflon's properties. The films rich in fluorine appear to have lower density, more hydrophobicity and lower friction coeficient than amorphous carbon films. They are also softer than them. The thermal annealing shows that films were thermally stable within temperatures up to 300oC. Above this temperature the films tend to loose fluorine and their properties change revealing a more graphitic structure.

New NMR Tools for Impurity Analysis was written by Jane Power and submitted for the degree of Doctor of Philosophy in the Faculty of Engineering and Physical Sciences at the University of Manchester, on 31st March 2016.NMR spectroscopy is rich in structural information and is a widely used technique for structure elucidation and characterization of organic molecules; however, for impurity analysis it is not generally the tool of choice. While 1H NMR is quite sensitive, due to its narrow chemical shift range (0 - 10 ppm) and the high abundance of hydrogen atoms in most drugs, its resolution is often poor, with much signal overlap. Therefore, impurity signals, especially for chemically cognate species, are frequently obscured. 19F NMR on the other hand offers extremely high resolution for pharmaceutical applications. It exhibits far wider chemical shift ranges (± 300 ppm) than 1H NMR, and typical fluorinated drugs, of which there are many on the market, have only one or two fluorine atoms. In view of this, 19F NMR is being considered as an alternative for low-level impurity analysis and quantification, using a chosen example drug, rosuvastatin. Before 19F NMR can be effectively used for such analysis, the significant technical problem of pulse imperfections, such as sensitivity to B1 inhomogeneity and resonance-offset effects, has to be overcome. At present, due to the limited power of the radiofrequency amplifiers, only a fraction of the very wide frequency ranges encountered with nuclei such as fluorine can be excited uniformly at any one time. In this thesis, some of the limitations imposed by pulse imperfections are addressed and overcome. Two new pulse sequences are developed and presented, CHORUS and CHORUS Oneshot, which use tailored, ultra-broadband swept-frequency chirp pulses to achieve uniform constant amplitude and constant phase excitation and refocusing over very wide bandwidths (approximately 250 kHz), with no undue B1 sensitivity and no significant loss in sensitivity. CHORUS, for use in quantitative NMR, is demonstrated to give accuracies better than 0.1%. CHORUS Oneshot, a diffusion-ordered spectroscopic technique, exploits the exquisite sensitivity of the 19F chemical shift to its local environment, giving excellent resolution, which allows for accurate discrimination between diffusion coefficients with high dynamic range and over very wide bandwidths. Sulfur hexafluoride (SF6) is investigated and shown to be a suitable reference material for use in 19F NMR. The bandshape of the fluorine signal and its satellites is simple, without complex splitting patterns, and therefore good for reference deconvolution; in addition, it is sufficiently soluble in the solvent of choice, DMSO-d6.To demonstrate the functionality of the CHORUS sequences for low-level impurity analysis, 470 MHz 1H decoupled 19F spectra were acquired on a 500 MHz Bruker system, using a degraded sample of rosuvastatin, to reveal two low-level impurities. Using a standard Varian probe with a single high frequency channel, simultaneous 1H irradiation and 19F acquisition was made possible by time-sharing. Simultaneous 19F{1H} and 19F{13C} double decoupling was then performed using degraded and fresh samples of rosuvastatin, to reveal three low-level impurities (in the degraded sample) and low-level 1H and 13C modulation artefacts.

La synthèse d’une nouvelle famille d’ènediynes comportant un motif perfluoré a été réalisée en 6 à 7 étapes. Leur activité anticancéreuse a été étudiée sur un panel de lignées cellulaires provenant de différents tissus ; des IC50 de l’ordre du µM ont été obtenus. Leur réponse en IRM du fluor 19 a aussi été évaluée, dans le but d’impliquer ces composés en théranostique (association de la thérapie et du diagnostic). Une étude mécanistique a été menée afin de comprendre le mécanisme biologique en jeu au cœur des cellules.Les ènediynes ont souvent vu leur développement stoppé en raison d’effets secondaires trop importants. Afin d’anticiper cette problématique, des stratégies de ciblage ont été développées pour nos composés. Dans un premier temps, la réponse à l’irradiation UV de nos composés a été mesurée. Dans un second temps, leur encapsulation dans des micelles polymériques a été réalisée.Enfin, dans un projet plus fondamental, la réactivité de substrats ènediynes et diène-ynes a été étudiée. Des cycloisomérisations procédant avec double transfert de chiralité ont été développées, permettant l’accès à des benzofulvènes et indènes. Deux variantes d’une réaction tandem d’Alder-Ene conduisant à des allyl-indènes ont aussi été décrites. / Synthesis of a new family of enediynes bearing a perfluorinated moiety was reached in 6 to 7 steps. Their anticancer activity was studied on a cell line panel from different tissues; IC50 values in the µM range were obtained. Their 19 fluorine MRI response was also evaluated, in order to involve them in a theranostic strategy (association of therapy and diagnosis). A mechanistic study was conducted to understand the biological mechanism at stake inside cells.Enediynes often saw their development stopped because of harmful side effects. To anticipate this problem, targeting strategies were developed for our compounds. First, their response to UV irradiation was measured. We then succeeded in their encapsulation inside polymeric micelles.Finally, in a more fundamental project, reactivity of enediyne and diene-yne substrates was studied. Cycloisomerisations proceeding with a double chirality transfer were developed, allowing access to benzofulvenes and indenes. Two variations of a tandem Alder-Ene reaction leading to allyl-indenes were also described.

Incident ¹H⁺ and ⁴He⁺ ions at 0.3-2.6 MeV and ¹⁹F^q⁺ ions at 25, 27 and 35 MeV were used to study the M-shell x-ray production cross sections of Au, Pb, Bi and U. For the incident fluorine ions, projectile charge state dependence of the cross sections were extracted from measurements made with varying target thicknesses ( ~1 to ~300 μg/cm²). The efficiency of the Si(Li) detector was determined by measuring the K-shell x-ray production of various low Z elements and comparing these values to the prediction of the CPSS theory. The experimental results are compared to the prediction of first Born approximation for direct ionization to the continuum and to the OBK of Nikolaev for the electron capture to the K-, L-, M-...shells of the incident ion. Comparison is also made with the ECPSSR theory that accounts for the energy loss, Coulomb deflection, and relativistic effects in the perturbed stationary state theory.

In this thesis, the construction of the allylic fluorides under palladium catalysis was investigated. Chapter 1 provides a general introduction to organofluorine compounds and the use of palladium for the formation of both Csp²- and Csp³-F bonds. The aims of the thesis are presented. In Chapter 2 the identification that a p-nitrobenzoate is the optimum leaving group under Pd-catalysis to give allyl fluorides is described. A range of allylic fluorides was synthesized in 35->95% yield using the nucleophilic fluorinating reagent, TBAF(tBuOH)₄. To further develop this transformation we have examined the effect of a variety of leaving groups and phosphine ligands. This methodology led to the development of the first transition metal mediated C-¹⁸F bond formation. The development of Ir-catalysed fluorination of allylic carbonates to give allylic fluorides is also discussed. This system provided access to branched, E- and Z-linear allylic fluorides in a regioselective manner. This methodology was also translated to ¹⁸F radiochemistry. In Chapter 3 the synthesis of allylic fluorides via a C-H functionalisation with Pd and nucleophilic source of fluorine was investigated. Comprehensive screening of Pd sources, fluoride reagents and additives was performed. The presence of a quinone was found to be crucial for this transformation. Chapter 4 describes the synthesis and characterization of a series of allylpalladium(II) complexes and their subsequent reactivity towards a range of electrophilic fluorination reagents. Chapter 5 gives full experimental procedures and characterization data for all compounds.

La synthèse de nouveaux radiotraceurs permettant un diagnostic précoce de la maladie d'Alzheimer par imagerie par tomographie de Positron (TEP) est en plein essor. Des dérivés d'inositols, ayant montré des propriétés d'agrégation vis-à-vis des plaques amyloïdes, ont été choisis comme plateforme, afin de concevoir et de synthétiser de nouveaux traceurs pour cette maladie. Quatre générations de radiotraceurs ont été conçues. La première génération est le scyllo-inisitol dont un des hydroxyles est remplacé par un fluor-18. Les secondes et troisièmes générations correspondent à des inositols de configuration myo et scyllo sur lesquels est accroché un bras-espaceur carboné de 1 à 3 atomes de carbone portant le fluor-18. Ceci permettra de conserver la structure de l'inositol. La dernière génération correspond à un inositol sur lequel le bras carboné portant le fluor est additionné par création d'un lien de type éther. La synthèse de cette famille de molécules permet ainsi d'obtenir un bras plus long. / The synthesis of new radiotracers to diagnose earlier Alzheimer's disease by Positron Emission Tomography (PET) is a rapidly growing field. Inisitol derivatives, which show aggregative properties to amyloid plaques, have been chosen as scaffold to create and synthesize new radiolabelled compounds for a early diagnostic. Four types of radiotracers have been designed. The first one is the scyllo-inositol in which one hydroxyl group is replaced by a fluorine-18. The second and third generations are inositols in myo and scyllo configurations where the fluorine-18 atom is carried by an alkyl chain. The structure of inositols is then preserved. Finally for the last generation, the alkyl chain bearing the fluorine-18 is introduced via an ether linkage. The synthesis of this type of molecules allows the incorporation of a longer spacer.

La neuroinflammation joue un rôle important dans de nombreuses maladies neurodégénératives telles que la maladie d’Alzheimer, Parkinson, ou encore la sclérose en plaques. De récents développements en imagerie moléculaire permettent aujourd’hui un meilleur diagnostique et un meilleur suivi thérapeutique de ces maladies. Parmi les techniques d’imagerie dont nous disposons actuellement, la Tomographie par Emission de Positions (TEP) et Tomographie par Emission Mono Photonique (TEMP) jouent un rôle important de par leur haute sensibilité et leurs aspects quantitatifs. L’objectif de ma thèse est de développer de nouveaux ligands et radioligands dédiés à l’imagerie de cibles spécifiques impliquées dans les processus de neuroinflammation. Pour ce faire, la TEP et ses émetteurs de positons à vie brève associés (notamment le fluor-18 ; T1/2 : 109.8 min) constituent un outil de choix. Le projet est divisé en deux sections principales. La première est dédiée au développement de ligands ciblant la protéine de Translocation 18 kDa (TSPO). Cette protéine est aujourd’hui reconnue comme un biomarqueur précoce des processus neuroinflammatoires, et de nombreux ligands ont déjà été synthétisés pour cette cible. Le plus anciens d’entre eux est le PK11195 appartenant à la famille des isoquinoléines, qui a été marqué au carbone-11 à la fin des années 80. Plus récemment, d’autres familles de composés ont vu le jour, et notamment la familles des pyrazolopyrimidines avec le [11C]DPA-713, ainsi que celle des pyridazinoindoles avec le [11C]SSR180575. A travers cette première partie de ma thèse, l’objectif est de synthétiser et de caractériser in vitro de nouveaux ligands dérivés des deux composés leaders de ces deux familles. Les précurseurs de marquage correspondant ont également été synthétisés pour les composés les plus prometteurs, permettant ainsi un radiomarquage au fluor-18. Certains résultats ont par ailleurs été présentés lors d’un congrès international (21st International Symposium on Radiopharmaceutical Sciences (Columbia, MO, USA – Mai 26-31, 2015)). La seconde partie de ma thèse est dédiée au développement de ligands pour des cibles alternatives à la TSPO, qui sont les récepteurs cannabinoïdes de type 2 (CB2R), et les récepteurs purinergiques P2Y12 et P2Y14. Ces nouvelles cibles, récemment émergées présentent un fort potentiel pour de nouvelles opportunités en imagerie. Une nouvelle série de sept composés a par ailleurs déjà été synthétisée en ce qui concerne le CB2R. Les précurseurs des molécules les plus prometteuses ont également été préparés. La synthèse des ligands dédiés aux récepteurs purinergiques a été initiée, et un premier couple référence /précurseur a été obtenu. / Neuroinflammation plays an important role in many neurodegenerative diseases (Alzheimer, Parkinson, Multiple sclerosis …) and recent developments in molecular imaging provide today new insights into the diagnostic and the treatement managment of these diseases. Among the existing imaging techniques, the highly sensitive and quantitative nuclear modalities SPECT (single photon emission computed tomography) but especially PET (positron emission tomography) play key roles. My PhD program is devoted to the design and synthesis of novel radioligands, all dedicated to the imaging of specific targets and processes linked to neuroinflammation. For this, PET and the short-lived positron-emitter fluorine-18 (T1/2: 109.8 min) remain the main focuses. The project has been divided into two sections, the first one concentrates on the development of novel ligands targeting the Translocator Protein 18 kDa (TSPO). Indeed, this target is today recognized as an early biomarker of neuroinflammatory processes and PK11195, an isoquinoline carboxamide labelled with carbon-11, was, in the late 80’s, the first reported PET-radioligand. More recently, new compounds, all belonging to different chemical classes, have emerged and notably the pyrazolopyrimidine acetamide [11C]DPA-713 and the pyridazinoindole acetamide [11C]SSR180575. Within the first section of my PhD, novel derivatives of both DPA-713 and SSR180575 have been synthesized and in vitro characterized. Dedicated precursors for labelling were also developed for the most promising candidates, and radiolabelling has been performed. Some results have been presented at the 21st International Symposium on Radiopharmaceutical Sciences (Columbia, MO, USA – May 26-31, 2015).The second part of my PhD, deals with the development of ligands for alternative targets to the TSPO, like the type-2 cannabinoid receptor (CB2R) and the purinergic P2Y14 / P2Y12 receptors, the latter emerging today as a hot topic for imaging opportunities. Up to now, a series of seven compounds targeting the CB2R has been successfully synthetized and in vitro characterized. Dedicated precursors of the most promising compounds have also been prepared and labelling will be shortly performed. The synthesis of ligands targeting the purinergic receptors has also been initiated and a first couple of reference / precursor has been obtained for the P2Y12R.

Le radiomarquage des macro-biomolécules au fluor-18 représente un défi majeur en radiochimie vu leur importance en imagerie moléculaire. Les macro-biomolécules et en particulier les peptides offrent une diversité moléculaire et un ciblage in vivo souvent plus spécifiques et sélectifs que les molécules de plus faibles poids moléculaires. Cependant, les conditions standards de radiomarquage au fluor-18 seraient destructrices pour de tels composés et ne peuvent être utilisées directement. Peu de méthodes directes de radiomarquage existent et présentent certains inconvénients (température encore élevée, activité molaire faible, méthodes peu versatiles…). C’est pourquoi, le radiomarquage par approche prosthétique en deux étapes reste une méthode de choix. Cette stratégie séquentielle implique tout d’abord la préparation d’une molécule radiofluorée, appelée groupe prosthétique, puis sa conjugaison à la macro-biomolécule dans des conditions chimiques biocompatibles. L’objectif de ce travail de thèse a consisté à développer de nouvelles méthodes générales de radiomarquage de macro-biomolécules visant in fine des applications de radiomarquage direct in vivo. Les enjeux principaux ont été la diminution du temps de marquage pour améliorer les procédés de radiosynthèse compte tenu de la demi-vie du fluor-18 (109,8 min), le besoin d’automatisation ainsi que la vitesse et la bioorthogonalité des réactions de conjugaison pour des applications en milieu complexe et dilué. Tout d’abord, l’étude de trois réactions de chimie click, CuAAC, SPAAC et SPSAC, de vitesse et de biocompatibilité croissantes a été considérée. Le développement de groupes prosthétiques spécifiques de chacune d’entre elles ainsi que leur conjugaison sur des composés modèles ont ensuite été étudiés. Par la suite, une étude méthodologique sur la radiofluoration de pyridines substituées a été initiée afin d’obtenir des entités radiomarquables dans des conditions suffisamment douces permettant la « pré-conjuguaison » à la macro-biomolécule avant l’étape de radiofluoration. Enfin, l’utilisation d’un étiquetage enzymatique, le SNAP-tag, a également été explorée et un substrat radiofluoré spécifique synthétisé. Ces différentes approches ont permis d’élargir le panel des méthodes permettant un radiomarquage efficace et biocompatible de macro-biomolécules. / Fluorine-18 radiolabeling of biologics is a challenge in radiochemistry due to their increasing interest in molecular imaging. Biologics, and particularly peptides, offer molecular diversity and often higher specific and selective in vivo targeting compared to low molecular weight molecules. However, fluorine-18-radiolabeling standard conditions could not be used directly because biologics would suffer from these drastic conditions. Only a few direct radiolabeling methods are available and present some drawbacks (high temperature, low molar activity, lack of versatility…). Therefore, a two-steps prosthetic radiolabeling approach remains the method of choice. This sequential strategy involves the preparation of a fluorine-18-labeled molecule, called prosthetic group, which is then conjugated with the macromolecule in biocompatible chemical conditions. The aim of this PhD work was to develop new general methods for the radiolabeling of biologics directed toward in vivo radiolabeling applications. Major issues were time and radiosynthesis processes with regard to the fluorine-18 half life, automatization as well as constant rate and bioorthogonality of conjugation reactions for applications in complex and diluted environment.The first part is devoted to the study of three click chemistry reactions, CuAAC, SPAAC and SPSAC leading to enhanced reaction rates and biocompatibility. Specific prosthetic groups were developed for each reaction and their conjugation was studied with model compounds. Furthermore, a methodological study involving the radiofluorination of substituted pyridines was initiated for the production of entities for mild radiolabeling conditions compatible with a “pre-conjugation” to the biologics before radiofluorination. Finally, an enzymatic labeling approach using the SNAP-tag self-labeling enzyme was explored and a specific radiofluorinated substrate was synthesized. These different approaches allowed an extent of the panel of methods for effective and biocompatible radiolabeling of biologics.